Please enter your name here Share on Facebook Tweet on Twitter UF/IFAS in Apopka will temporarily house District staff; saves almost $400,000 TAGSCollegetheconversation.com Previous articleJoin The Apopka Voice team: Sales Associate neededNext articleApopka Burglary Report Denise Connell RELATED ARTICLESMORE FROM AUTHOR Part One – Rating the colleges You have entered an incorrect email address! Please enter your email address here LEAVE A REPLY Cancel reply Editor’s note: Today we begin a new series in which we ask the leaders of our country’s colleges and universities to address some of the most pressing issues in higher education. This series was first published on theconversation.com.The past several years have seen increased calls for colleges and universities to demonstrate their value to students, families, and taxpayers. And the pressure has come from both sides of the political spectrum. Barack Obama, for example, didn’t mince his words when he spoke a few years ago on the University of Michigan campus: “We are putting colleges on notice…you can’t assume that you’ll just jack up tuition every single year. If you can’t stop tuition from going up, then the funding you get from taxpayers each year will go down. We should push colleges to do better.”So how is a would-be student or a tax-paying citizen to decide the value of a given university or degree? There is certainly no shortage of tools that have been developed to help in this regard.The federal College Scorecard, for example, is meant to “help students choose a school that is well-suited to meet their needs, priced affordably, and is consistent with their educational and career goals.” Whether those goals are medicine, teaching, getting a sport business degree, or any other area of interest, the College Scorecard can help.Various magazines put together college rankings. There have been efforts at the state level to show what graduates of a given institution or program can expect to earn. And some colleges and universities are working to provide those data themselves.So we asked our panel of presidents – from the University of Michigan, University of Oregon and The Ohio State University: If you had to devise just one tool or metric to help the general public assess the value of a particular college or degree, what would it be and why?Greater life expectancyMichael Drake, president of The Ohio State UniversityMichael Drake, president of The Ohio State University. The Ohio State UniversityWhen I ask individuals if they want their own children to attend college, the answer is, overwhelmingly, yes. The evidence is clear. College graduates are more likely to be employed and more likely to earn more than those without degrees. Studies also indicate that people with college degrees have higher levels of happiness and engagement, better health and longer lives.Wow.If living a longer, healthier and happier life is a good thing, then, yes, college is worth it.A four-year degree is not necessarily the best path for everyone, of course. Many people find their lives are enhanced by earning a two-year or technical degree. For others, none of these options is a perfect choice. But if there is one data point I want to highlight, it is the correlation between a college education and greater life expectancy. In fact, one study suggests that those who attend college live, on average, seven years longer.Last year was the second year in a row that average life expectancy in the U.S. went down. But greater mortality didn’t affect all Americans equally. Studies point to a growing gap in life expectancy between rich and poor. Higher education may, in other words, be part of the solution to this problem.This is just one of the reasons that so many of our country’s institutions of higher learning are focused on the question of how to make sure more Americans have access to a quality – and affordable – college education.Since December 2016, the American Talent Initiative, a coalition of 100 (and counting) colleges and universities, has been working to educate 50,000 additional lower-income students by 2025. In another initiative, the 11 public universities in the University Innovation Alliance are committed to producing more U.S. graduates and have, over the past three years, increased their number of low-income graduates by 24.7 percent.As educators, we must continue to increase pathways to the American Dream — a journey that includes health, happiness, long life and, very often, a college degree.Social mobilityMichael Schill, president of the University of OregonMichael Schill, president of the University of Oregon. University of Oregon, Author providedWhile it is impossible to devise only one indicator to describe the value of a university, I would suggest that a good place to begin would be the number of first-generation students it admits and the rate at which they graduate.As a first-generation college student myself, I may be somewhat biased, but I believe that our generation will be judged by how well we enhance the opportunities for social mobility among our citizens. And despite some skepticism about the value of higher education on the part of pundits and politicians, it is well-documented that there is no better way for young people to achieve the “American Dream” than by getting a college degree.Note that my metric is really two – first-generation enrollment numbers and graduation rates. The simple fact is that students who go to college and don’t receive a degree may well be in worse shape economically than those who don’t go at all. They will have invested time and money, yet without a diploma will not achieve the economic returns from that investment. Moreover, many are hobbled by student loans without the economic wherewithal to repay them.It is easy for universities, colleges and community colleges to admit large numbers of students from modest backgrounds. That happened in the for-profit sector. However, the graduation rate at for-profit institutions is only 23 percent, compared to the 59 percent rate overall. The hard part is to support students so that they can succeed.First-generation students make up a third of college undergraduates in the United States. They are more likely to be minorities and to come from low-income households, and are far less likely to graduate than their peers who had one or more parent attend college. We can do better.Part of the solution is for more universities to provide more adequate need-based financial assistance, but even that isn’t enough. College can be a confusing experience for first-generation kids, both in terms of learning how to succeed academically and “fitting in” socially. The real value will accrue to students and American society only if we can provide them with appropriate advising and counseling so that they not only get in but persist and flourish.FreedomMark Schlissel, president of the University of MichiganMark S. Schlissel, president of the University of Michigan. University of MichiganTo devise one metric to help the public assess our value, we need to challenge ourselves the same way we challenge students in our classrooms and labs. Let’s first determine the right question to ask. What are our students looking for in life and how can a college degree change the quality and trajectory of their lives?Higher education gives graduates the best opportunity to pursue their ambitions, change careers, define and solve complex problems, and persuade and lead others. College graduates enjoy higher salaries, qualify for further levels of education and are at a lower risk of ending up in jobs that become obsolete. Moreover, they lead richer and fuller lives – happier, healthier, wealthier and longer.Each of these outcomes is a component of the value of a college education, yet none of them alone fairly captures its full value. In considering these metrics together, in the context of our question, I believe that one very important concept emerges.That concept is freedom.Freedom’s link to education has long been a quintessential American value. As the educator and philosopher, John Dewey wrote at the beginning of the 20th century, “We naturally associate democracy, to be sure, with freedom of action, but freedom of action without freed capacity of thought behind it is only chaos.”At its best, higher education gives us the freedom to make decisions based on our values, desires, human talents and willingness to work hard. We are free to choose our own path.Education takes freedom beyond its status as a legal right and elevates it into a lifetime of choices. It’s the trajectory of those lives, changed by the opportunities available through a college education, that I am most interested in measuring.The American public rightfully expects higher education to serve as an enabler of prosperity and equality. I would devise a metric that captures higher education’s greatest potential: to enhance the freedom of an individual graduate in a nation founded on constitutionally guaranteed rights of life, liberty and the pursuit of happiness.Editor’s note: The Ohio State University is a member of the University Innovation Alliance and American Talent Initiative. By Mark S. Schlissel, President, University of Michigan, Michael H. Schill, President, University of Oregon, and Michael V. Drake, President The Ohio State University. Gov. DeSantis says new moment-of-silence law in public schools protects religious freedom Save my name, email, and website in this browser for the next time I comment. Please enter your comment! Florida gas prices jump 12 cents; most expensive since 2014
Did you know that while we humans are 99.9 percent identical at the genome level, it is the 0.1 percent variation that explains many of our individual traits, including our susceptibility to diseases?[i]“Rare” diseaseDid you also know that what is termed “rare disease” is actually not so rare, as modern medical discoveries continue to reveal novel conditions that limit people’s everyday lives and were previously undiagnosed and untreated? According to Rare Disease UK[ii], there are between 6,000 and 8,000 known rare diseases with around five new rare diseases described in medical literature each week. Actually, one in 17 people around the globe will be affected by some form of rare disease, either seriously or in a less serious form. In fact, the carriers of rare diseases globally are easily equivalent to the population of a large country.And, to add to this, there is of course cancer, which comprises a genetic disease category in its own right. Non-medical people, like me, tend to forget that cancer isn’t just one disease – it’s actually hundreds of diseases forming thousands of combinations, each requiring a personalized and adjustable treatment plan.Modern personalized diagnosticsThe good news is that over the past ten years, tremendous biotechnological advances have not only changed the way we diagnose and treat genetic disease (and other more common disorders) but have also created a wealth of biomedical data. This has contributed hugely to our genetic disease knowledge, leading to a self-feeding loop of improved diagnosis and treatment. The key technology – Next Generation Sequencing (NGS) – allows for cheap, fast and accurate acquisition of a person’s whole or partial genome with countless applications, spanning disease diagnosis treatment to lifestyle decisions.Rapid diagnosisGoing back to disease susceptibilities, were you aware that genetic disorders are a leading cause of infant deaths? Unfortunately, diagnosing acutely ill babies is a race against the clock. While standard diagnostic methods are usually too slow to make a difference, an NGS technique called Whole Genome Sequencing (WGS) can meet the critical time window to save lives. As WGS has become more affordable, it is also becoming more broadly available to patients. Today, new-born screening is currently available for about 60 genetic diseases with more to follow. As Dr. Stephen Kingsmore, President and CEO of Rady Children’s Institute for Genomic Medicine said, “Rapid diagnosis of critically ill newborns is no longer an academic exercise; it’s a reality for critically ill new-borns.”In addition to new-born disease screening, WGS is also used to end the diagnostic odyssey of children and adults, who suffer from unusual genetic disorders and cannot reach a diagnosis through traditional methods.Immune and gene therapyLikewise, immune therapy and gene therapy – the process of treating an acquired disease like cancer either by using the patient’s own immune cells or by modifying their DNA – is also part of the present-day clinical treatment toolkit. This high accuracy, ultra-rapid method allows the simultaneous evaluation of nearly all 5,000 known genetic diseases in a single test, all enabled by guess what? Yes, believe it or not – a high-performing IT technology compute and storage solution!Precision medicineThese are two great examples of what the healthcare industry calls precision medicine – treatments that look at the genetic profile and genetic characteristics of the patient as well as the specific disease that the patient is dealing with. Using this information, doctors are then able to create a personalized treatment plan for each patient that continues to evolve and adapt as required.How we support healthcareAs western healthcare systems creak under the pressure of aging populations with chronic diseases and not enough funding to cope, health care authorities and hospitals are rapidly moving to adopt big game changers, like whole genome sequencing.Globally, we at Dell EMC OEM are working with a number of specialist companies in this field, sharing our expertise on the underlying compute and storage technology involved. For example, one of our partners, HybridStat has developed Geniasis, a DNA analytics platform, powered by Dell EMC architecture, which performs WGS analysis for diagnostic purposes. HybridStat also offers bioinformatics consulting services to life scientists.Deepening understanding and enabling new productsWe also work with organisations like Genomics England, Genomics Scotland, Genomics France and Genomics Wales, who do great work to expand the medical world’s understanding of diseases. For example, at the end of 2018, Genomics England achieved its goal of sequencing 100,000 genomes from around 85,000 people.[iii] This project – the largest national sequencing project of its kind worldwide – is enhancing researchers’ understanding of diseases while also supporting the development of products for earlier detection and treatment. You can read more about our work with Genomics England here.In a separate development, the British Government also announced plans last year to use artificial intelligence to diagnose cancer at earlier stages, which they believe will prevent 22,000 deaths by 2023.[iv]IT technology has enabled progressWhat has driven this revolution? Of course, medical research has made and continues to make huge advances but there’s no doubt that IT technology has been a significant enabler. Up until now, genome scale data management, annotation, interpretation and reporting were expensive and complicated, especially for clinical purposes.Now, thanks to rapid IT technology developments, DNA sequencing has become faster and cheaper with scientists now sequencing an entire genome in 22 minutes, while the process previously took days.[v] However, despite such advanced progress, experts say that the whole genome sequencing process needs to become even more automated if it is to realize its full potential.The rocket fuelHow do we get to this next stage? Of course, it goes without saying that we need scientists and continued investment in medical research. However, researchers also need the right tools like high performance computing and storage. The current estimate is that up to two billion genomes will be sequenced by 2025 and that storing, and processing genome data will reach up to 40 exabytes, exceeding the computing challenges of running YouTube and Twitter.[vi]Advances in IT technology have brought genomics within the reach of mainstream healthcare. Over the long-term, I believe that all these combined developments will transform patient care, leading to faster diagnosis and breakthrough treatments. The idea that technology should be a driver of human progress is central to how we think as a company – it’s all part of our commitment to Dell4Good, where we put our technology and expertise to work to improve lives.What are your views? I would love to hear your comments and questions. Come meet us at HIMSS19, Booth # 3159 in Orlando, Florida, February 11-15. Meet our experts, experience our demos and hear directly from customers discussing their successful technology deployment in Health IT Transformation, Precision Medicine, Connected Health, and Security. To learn more about Dell EMC OEM Solutions, visit: https://www.dellemc.com/en-us/oem/healthcare.htmKeep in touch. Follow us on Twitter @DellEMCOEM, and join our LinkedIn OEM & IoT Solutions Showcase page here.[i] https://www.genome.gov/19016904/faq-about-genetic-and-genomic-science/[ii] https://www.raredisease.org.uk/what-is-a-rare-disease/[iv] https://www.gov.uk/government/news/pm-to-set-out-ambitious-plans-to-transform-outcomes-for-people-with-chronic-diseases[v] https://www.emc.com/collateral/solution-overview/h15368-dell-emc-edico-genome-so.pdf[vi] https://www.nature.com/news/genome-researchers-raise-alarm-over-big-data-1.17912
Future direct EU access will depend on whether Brussels deems UK regulation to be “equivalent” to standards in the bloc.Although it is far more limited than current access, without equivalence EU investors would not be able to use financial services in London.“COVID-19 has the potential to disrupt Brexit planning including impacting client readiness, as well as potentially affecting the ability of firms to relocate staff to other jurisdictions,” AFME said in a statement.AFME said ensuring that EU investors can continue using clearing houses in London needed addressing before the end of September to avoid customers having to move derivatives positions elsewhere. Two-way access in stock and derivatives trading was also needed to avoid disruption, AFME said.AFME called for a formal framework for UK and EU regulators to iron out differences that could jeopardise access.“This is particularly important in the context of the fast-evolving legislative agenda in the EU and the UK with a number of significant financial services files being proposed, due to be implemented, or under review in the second half of this year and the first half of 2021,” AFME said.The EU’s chief Brexit negotiator Michel Barnier said last week that financial firms must get ready for big changes in January.“We will only grant equivalences in those areas where it is clearly in the interest of the EU, of our financial stability, our investors and our consumers,” Barnier said.Topics : Britain and the European Union need to make progress on EU financial market access given that the coronavirus crisis will make it even harder to cope with potential disruption if there is no agreement, banking lobby AFME said on Monday.Britain left the EU in January but has full access to the bloc under a transition period that runs until the end of December.London and Brussels blamed each other last week for missing a June 30 deadline for assessments on financial market access from January.